Table 1.
Patient demographics | Frequencies/means (SD) |
---|---|
Male | 25/45 (56%) |
Mean age at symptom onset (years) | 7.5 (SD 2.5) |
Mean age at intake (years) | 9.0 (SD 3.1) |
Developmental abnormalities (psychomotor, language disorder, and/or learning disability) | 8/45 (18%) |
Preexisting psychiatric/neuropsychiatric diagnoses | 8/45 (18%) |
Preexisting autoimmune disease or inflammatory disorder | 11/45 (24%) |
CGAS at intakea | 50 (SD 10.1) |
CGI-S at intake | 3.8 (SD 0.9) |
Acute symptom onset | 42/45 (93%) |
Infection in temporal relation to symptom onset | 42/45 (93%) |
Onset of autoimmune disease or inflammatory disorder in temporal relation to symptom onset | 7/45 (16%) |
Available for 43 patients only.
CGAS, Children's Global Assessment Scale; CGI-S, Clinical Global Impressions-Severity Scale; SD, standard deviation.